Intracellular bacterial vectors that induce CD8(+) T cells with similar cytolytic abilities but disparate memory phenotypes provide contrasting tumor protection.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Research

• Publication date

  2009-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-08-3160PMID 19435919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B

  2008cited by this paper
• Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy.

  2008cited by this paper
• Pathogen Proliferation Governs the Magnitude but Compromises the Function of CD8 T Cells1

  2008cited by this paper
• Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth

  2007cited by this paper
• Virosome-mediated delivery of tumor antigen to plasmacytoid dendritic cells.

  2007cited by this paper
• Adoptive T cell therapy for cancer in the clinic.

  2007cited by this paper
• Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer

  2007cited by this paper
• Comparative Prime-Boost Vaccinations Using Semliki Forest Virus, Adenovirus, and ALVAC Vectors Demonstrate Differences in the Generation of a Protective Central Memory CTL Response against the P815 Tumor1

  2007cited by this paper
• Persistent Depots of Influenza Antigen Fail To Induce a Cytotoxic CD8 T Cell Response1

  2007cited by this paper
• Salmonella–Host Cell Interactions, Changes in Host Cell Architecture, and Destruction of Prostate Tumor Cells with Genetically Altered Salmonella

  2007cited by this paper
• Listeriolysin O-Deficient Listeria monocytogenes as a Vaccine Delivery Vehicle: Antigen-Specific CD8 T Cell Priming and Protective Immunity1

  2006cited by this paper
• Delayed Expansion and Contraction of CD8+ T Cell Response during Infection with Virulent Salmonella typhimurium1

  2006cited by this paper
• CD8+ T‐cell memory in tumor immunology and immunotherapy

  2006cited by this paper
• Initial T cell frequency dictates memory CD8+ T cell lineage commitment

  2005cited by this paper
• Characterization of anti-self CD8 T-cell responses stimulated by recombinant Listeria monocytogenes expressing the melanoma antigen TRP-2.

  2005cited by this paper
• Reducing the Stimulation of CD8+ T Cells during Infection with Intracellular Bacteria Promotes Differentiation Primarily into a Central (CD62LhighCD44high) Subset1

  2005cited by this paper
• Differential contributions of central and effector memory T cells to recall responses

  2005cited by this paper
• What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors

  2005cited by this paper
• Vaccine-Induced CD8+ Central Memory T Cells in Protection from Simian AIDS

  2005cited by this paper
• Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells.

  2005cited by this paper
• A Novel Role of IL-15 in Early Activation of Memory CD8+ CTL after Reinfection1

  2005cited by this paper
• Genetically programmed B lymphocytes are highly efficient in inducing anti-virus protective immunity mediated by central memory CD8 T cells.

  2004cited by this paper
• Differential Tissue-Specific Regulation of Antiviral CD8+ T-Cell Immune Responses during Chronic Viral Infection

  2004cited by this paper
• The paradox of T cell–mediated antitumor immunity in spite of poor clinical outcome in human melanoma

  2004cited by this paper
• Maintenance, Loss, and Resurgence of T Cell Responses During Acute, Protracted, and Chronic Viral Infections1

  2004cited by this paper
• IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells

  2004cited by this paper
• Prolonged Antigen Presentation, APC-, and CD8+ T Cell Turnover during Mycobacterial Infection: Comparison with Listeria monocytogenes1

  2004cited by this paper
• Cutting Edge: Rapid In Vivo Killing by Memory CD8 T Cells1

  2003cited by this paper
• Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma.

  2003cited by this paper
• Cytokine control of memory T-cell development and survival

  2003cited by this paper
• Maintenance and attrition of T-cell memory.

  2003cited by this paper
• Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells

  2003cited by this paper
• Lineage relationship and protective immunity of memory CD8 T cell subsets

  2003cited by this paper
• Cancer vaccines: between the idea and the reality

  2003cited by this paper
• Multiple Mechanisms Compensate to Enhance Tumor-Protective CD8+ T Cell Response in the Long-Term Despite Poor CD8+ T Cell Priming Initially: Comparison Between an Acute Versus a Chronic Intracellular Bacterium Expressing a Model Antigen1

  2002cited by this paper
• Vaccines: Effector and memory T-cell differentiation: implications for vaccine development

  2002cited by this paper
• Cutting Edge: CCR7+ and CCR7− Memory T Cells Do Not Differ in Immediate Effector Cell Function1

  2002cited by this paper
• Interleukin (IL)-15 and IL-7 Jointly Regulate Homeostatic Proliferation of Memory Phenotype CD8+ Cells but Are Not Required for Memory Phenotype CD4+ Cells

  2002cited by this paper
• Migratory Properties of Naive, Effector, and Memory Cd8+ T Cells

  2001cited by this paper
• Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

  1999cited by this paper
• Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

  1999cited by this paper
• Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

  1999cited by this paper
• Functionally Heterogeneous CD8+ T-Cell Memory Is Induced by Sendai Virus Infection of Mice

  1999cited by this paper
• Salmonella vaccine carrier strains: effective delivery system to trigger anti‐tumor immunity by oral route

  1999cited by this paper
• Processing of Listeria monocytogenes antigens and the in vivo T‐cell response to bacterial infection

  1999cited by this paper
• Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function

  1998cited by this paper
• Immunological Memory and Protective Immunity: Understanding Their Relation

  1996cited by this paper
• Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice.

  1994cited by this paper

• Pivotal role of Helicobacter pylori virulence genes in pathogenicity and vaccine development

  2025cites this paper
• Culturing Potential: advances in ex vivo cell culture systems for haematopoietic cell-based regenerative therapies

  2025cites this paper
• Designing live bacterial therapeutics for cancer.

  2025cites this paper
• Exploiting bacteria for cancer immunotherapy

  2024influential citation
• Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity

  2023cites this paper
• Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria

  2023cites this paper
• Bacteria in cancer therapy: A new generation of weapons

  2022cites this paper
• EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity.

  2022cites this paper
• Identification and evaluation of a panel of strong constitutive promoters in Listeria monocytogenes for improving the expression of foreign antigens

  2021cites this paper
• Bacteria-Based Immune Therapies for Cancer Treatment.

  2021cites this paper
• Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies

  2021cites this paper
• Eliciting a potent antitumor immune response by expressing tumor antigens in a skin commensal

  2021cites this paper
• H2O2-Inactivated Salmonella typhimurium RE88 Strain as a New Cancer Vaccine Carrier: Evaluation in a Mouse Model of Cancer

  2021cites this paper
• RIPK3 and Caspase-1/11 Are Necessary for Optimal Antigen-Specific CD8 T Cell Response Elicited by Genetically Modified Listeria monocytogenes

  2020cites this paper
• An Intelligent Biomimetic Nanoplatform for Holistic Treatment of Metastatic Triple-Negative Breast Cancer via Photothermal Ablation and Immune Remodeling.

  2020cites this paper
• Immunological evaluation of virulence-deficient Listeria monocytogenes strains in C57BL/6 mice.

  2020cites this paper
• Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium.

  2020cites this paper
• Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy

  2019cites this paper
• Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica

  2018cites this paper
• Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors

  2017cites this paper
• An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma

  2017cites this paper
• Poly-functional and long-lasting anticancer immune response elicited by a safe attenuated Pseudomonas aeruginosa vector for antigens delivery

  2016cites this paper
• Homologous Prime-Boost Vaccination with OVA Entrapped in Self-Adjuvanting Archaeosomes Induces High Numbers of OVA-Specific CD8+ T Cells that Protect Against Subcutaneous B16-OVA Melanoma

  2016cites this paper
• Harnessing Stem Cell-Like Memory T Cells for Adoptive Cell Transfer Therapy of Cancer

  2015cites this paper
• Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery

  2015cites this paper
• Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy

  2014cites this paper
• Paths to stemness: building the ultimate antitumour T cell

  2012cites this paper
• Therapeutic live vaccines as a potential anticancer strategy

  2012cites this paper
• Lack of Functional Selectin Ligand Interactions Compromises Long Term Tumor Protection by CD8+ T Cells

  2012cites this paper
• Intracellular Facultative Bacterial Vectors for Cancer Immunotherapy

  2012cites this paper
• Escherichia coli Nissle 1917 Targets and Restrains Mouse B16 Melanoma and 4T1 Breast Tumors through Expression of Azurin Protein

  2012cites this paper
• A Risk Model for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: An Evidence-Based Proposal for Patient Selection

  2011cites this paper
• Tumor-Associated Antigen Expressing Listeria monocytogenes Induces Effective Primary and Memory T-Cell Responses Against Hepatic Colorectal Cancer Metastases

  2011cites this paper
• The Role of CD8+ T Cell Phenotype and Cytotoxicity on Cancer Immunotherapy

  2011cites this paper
• Caspase-3 Is Transiently Activated without Cell Death during Early Antigen Driven Expansion of CD8+ T Cells In Vivo

  2010cites this paper
• Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy.

  2010cites this paper
• Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment

  2010cites this paper